SPP100 Dose Finding Study in Japan
NCT00311012
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
445
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Aliskiren
Sponsor
Novartis